These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3503682)

  • 1. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action.
    Robertson HA; Robertson GS
    Clin Neuropharmacol; 1987 Aug; 10(4):384-7. PubMed ID: 3503682
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the treatment of Parkinson's disease.
    Rinne UK
    Acta Neurol Scand Suppl; 1980; 78():103-21. PubMed ID: 6945029
    [No Abstract]   [Full Text] [Related]  

  • 3. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 4. Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
    Rinne UK
    Neurology; 1987 May; 37(5):826-8. PubMed ID: 3574685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.
    Bouchard S
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):460-5. PubMed ID: 3676921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 7. A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa.
    Wallis WE
    Eur Neurol; 1988; 28 Suppl 1():9-10. PubMed ID: 3288479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of dopamine agonists in Parkinson's disease.
    Jankovic J
    Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
    BMJ; 1993 Aug; 307(6902):469-72. PubMed ID: 8400928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early dopamine agonist therapy in Parkinson's disease.
    Rinne UK
    Mov Disord; 1989; 4 Suppl 1():S86-94. PubMed ID: 2566915
    [No Abstract]   [Full Text] [Related]  

  • 11. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD; Delgado MR
    Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of Parkinson's disease with bromocriptine.
    Rascol A; Guiraud B; Montastruc JL; David J; Clanet M
    J Neurol Neurosurg Psychiatry; 1979 Feb; 42(2):143-50. PubMed ID: 422961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease.
    Rinne UK
    Mt Sinai J Med; 1988 Mar; 55(2):138-41. PubMed ID: 3260342
    [No Abstract]   [Full Text] [Related]  

  • 14. New perspectives in the treatment of Parkinson's disease.
    LeWitt PA
    Clin Neuropharmacol; 1986; 9 Suppl 1():S37-54. PubMed ID: 3085929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent progress of therapy in patients with Parkinson's disease].
    Yanagisawa N
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1109-14. PubMed ID: 8228492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine agonists as primary treatment in Parkinson's disease.
    Rinne UK
    Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
    Vardy J; Rabey JM; Streifler M
    Harefuah; 1977 Sep; 93(5-6):129-33. PubMed ID: 924233
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of parkinsonism with bromocriptine.
    Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
    Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjunctive therapy with bromocriptine in Parkinson's disease.
    Temlett JA; Ming A; Saling M; Fritz VU; Blumenfeld A; Bilchik TR; Becker AL; Fourie PB; Reef HE
    S Afr Med J; 1990 Dec; 78(11):680-5. PubMed ID: 2251616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.